Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1948 1
1962 1
1986 2
1987 1
1988 1
1991 1
1994 1
1995 1
1998 1
2000 1
2001 1
2003 1
2004 1
2005 3
2006 3
2007 1
2008 1
2010 4
2011 9
2012 4
2013 12
2014 7
2015 8
2016 3
2017 1
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21147758

67 results
Results by year
Filters applied: . Clear all
Page 1
Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.
Cooper PD, Petrovsky N. Cooper PD, et al. Glycobiology. 2011 May;21(5):595-606. doi: 10.1093/glycob/cwq201. Epub 2010 Dec 7. Glycobiology. 2011. PMID: 21147758 Free PMC article.
Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.
Cooper PD, Barclay TG, Ginic-Markovic M, Petrovsky N. Cooper PD, et al. Vaccine. 2014 Jan 23;32(5):552-7. doi: 10.1016/j.vaccine.2013.11.105. Epub 2013 Dec 14. Vaccine. 2014. PMID: 24342245 Free PMC article.
The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.
Cooper PD, Barclay TG, Ginic-Markovic M, Petrovsky N. Cooper PD, et al. Glycobiology. 2013 Oct;23(10):1164-74. doi: 10.1093/glycob/cwt053. Epub 2013 Jul 12. Glycobiology. 2013. PMID: 23853206 Free PMC article.
Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties.
Cooper PD, Steele EJ. Cooper PD, et al. Vaccine. 1991 May;9(5):351-7. doi: 10.1016/0264-410x(91)90063-c. Vaccine. 1991. PMID: 1872020
Development of soluble inulin microparticles as a potent and safe vaccine adjuvant and delivery system.
Kumar S, Tummala H. Kumar S, et al. Mol Pharm. 2013 May 6;10(5):1845-53. doi: 10.1021/mp3006374. Epub 2013 Apr 10. Mol Pharm. 2013. PMID: 23506468
Vaccine adjuvants based on gamma inulin.
Cooper PD. Cooper PD. Pharm Biotechnol. 1995;6:559-80. doi: 10.1007/978-1-4615-1823-5_24. Pharm Biotechnol. 1995. PMID: 7551236 Review.
Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.
Petrovsky N, Cooper PD. Petrovsky N, et al. Vaccine. 2015 Nov 4;33(44):5920-6. doi: 10.1016/j.vaccine.2015.09.030. Epub 2015 Sep 25. Vaccine. 2015. PMID: 26407920 Free PMC article. Review.
Anti-complementary action of polymorphic "solubility forms" of particulate inulin.
Cooper PD, Carter M. Cooper PD, et al. Mol Immunol. 1986 Aug;23(8):895-901. doi: 10.1016/0161-5890(86)90075-1. Mol Immunol. 1986. PMID: 3796631
Investigation of the biodistribution, breakdown and excretion of delta inulin adjuvant.
Wang L, Barclay T, Song Y, Joyce P, Sakala IG, Petrovsky N, Garg S. Wang L, et al. Vaccine. 2017 Aug 3;35(34):4382-4388. doi: 10.1016/j.vaccine.2017.06.045. Epub 2017 Jul 1. Vaccine. 2017. PMID: 28676380
Physical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation.
Barclay TG, Rajapaksha H, Thilagam A, Qian G, Ginic-Markovic M, Cooper PD, Gerson A, Petrovsky N. Barclay TG, et al. Carbohydr Polym. 2016 Jun 5;143:108-15. doi: 10.1016/j.carbpol.2016.01.062. Epub 2016 Jan 29. Carbohydr Polym. 2016. PMID: 27083349 Free PMC article.
67 results
Jump to page
Feedback